Press Releases about Vaxcyte Inc![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Vaxcyte to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023
February 16, 2023
From Vaxcyte, Inc.
Via GlobeNewswire
![]()
Vaxcyte to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From Vaxcyte, Inc.
Via GlobeNewswire
![]() ![]() From Vaxcyte, Inc.
Via GlobeNewswire
![]()
Vaxcyte to Present at Upcoming Investor Conferences
November 03, 2022
From Vaxcyte, Inc.
Via GlobeNewswire
![]() ![]() ![]()
Vaxcyte Announces Pricing of $600 Million Public Offering
October 26, 2022
From Vaxcyte, Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]()
Vaxcyte Expands Executive Leadership Team with Key Appointments
October 11, 2022
From Vaxcyte, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|